The process of angiogenesis refers to the growth of new blood vessels from existing ones. Tumours can produce factors in the micro-environment which act on blood vessels to promote angiogenesis. It is therefore considered to be fundamental in tumour progression and metastatic dissemination. This neovascularization can be regulated by numerous endogenous factors in the tumour micro-environment. As a result, anti-angiogenic therapies have been developed in the hope of targeting this process to reduce tumour growth and progression. However, only a proportion of patients respond to therapy, indicating the presence of treatment resistance in some. In this chapter, we aim to highlight the process of angiogenesis and to review pivotal evidence for the use of anti-angiogenic therapies thus far (alone and in combination with other agents). Finally, we will illustrate recent evidence for the discovery of biomarkers for anti-angiogenic therapies and potential mechanisms of resistance to such agents. Keywords: angiogenesis, tumour microenvironment, blood vessels, growth factor, stroma, anticancer therapies, biomarkers, resistance mechanisms
CITATION STYLE
Frentzas, S., Lum, C., & Chen, T.-Y. (2020). Angiogenesis and Its Role in the Tumour Microenvironment: A Target for Cancer Therapy. In Current Cancer Treatment. IntechOpen. https://doi.org/10.5772/intechopen.89667
Mendeley helps you to discover research relevant for your work.